BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32894711)

  • 21. Temporal and Spatial Analysis of Alzheimer's Disease Based on an Improved Convolutional Neural Network and a Resting-State FMRI Brain Functional Network.
    Sun H; Wang A; He S
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-modal discriminative dictionary learning for Alzheimer's disease and mild cognitive impairment.
    Li Q; Wu X; Xu L; Chen K; Yao L; Li R
    Comput Methods Programs Biomed; 2017 Oct; 150():1-8. PubMed ID: 28859825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDG-PET for Prediction of AD Dementia in Mild Cognitive Impairment. A Review of the State of the Art with Particular Emphasis on the Comparison with Other Neuroimaging Modalities (MRI and Perfusion SPECT).
    Sanchez-Catasus CA; Stormezand GN; van Laar PJ; De Deyn PP; Sanchez MA; Dierckx RA
    Curr Alzheimer Res; 2017; 14(2):127-142. PubMed ID: 27357645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies.
    Chiba Y; Fujishiro H; Iseki E; Kasanuki K; Sato K
    J Neuroimaging; 2019 Nov; 29(6):712-720. PubMed ID: 31199036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discriminative multi-task feature selection for multi-modality classification of Alzheimer's disease.
    Ye T; Zu C; Jie B; Shen D; Zhang D;
    Brain Imaging Behav; 2016 Sep; 10(3):739-49. PubMed ID: 26311394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.
    Cerami C; Della Rosa PA; Magnani G; Santangelo R; Marcone A; Cappa SF; Perani D
    Neuroimage Clin; 2015; 7():187-94. PubMed ID: 25610780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Artificial Intelligence on FDG PET Images Identifies Mild Cognitive Impairment Patients with Neurodegenerative Disease.
    Prats-Climent J; Gandia-Ferrero MT; Torres-Espallardo I; Álvarez-Sanchez L; Martínez-Sanchis B; Cháfer-Pericás C; Gómez-Rico I; Cerdá-Alberich L; Aparici-Robles F; Baquero-Toledo M; Rodríguez-Álvarez MJ; Martí-Bonmatí L
    J Med Syst; 2022 Jun; 46(8):52. PubMed ID: 35713815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal FDG-PET features for the classification of Alzheimer's disease.
    Rodrigues F; Silveira M
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():1941-4. PubMed ID: 25570360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-stage classification of Alzheimer's disease from
    Thakur M; Snekhalatha U
    Phys Eng Sci Med; 2022 Dec; 45(4):1301-1315. PubMed ID: 36357627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging.
    Choi H; Jin KH;
    Behav Brain Res; 2018 May; 344():103-109. PubMed ID: 29454006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early identification of mild cognitive impairment using incomplete random forest-robust support vector machine and FDG-PET imaging.
    Lu S; Xia Y; Cai W; Fulham M; Feng DD;
    Comput Med Imaging Graph; 2017 Sep; 60():35-41. PubMed ID: 28223022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 3D densely connected convolution neural network with connection-wise attention mechanism for Alzheimer's disease classification.
    Zhang J; Zheng B; Gao A; Feng X; Liang D; Long X
    Magn Reson Imaging; 2021 May; 78():119-126. PubMed ID: 33588019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy.
    Smailagic N; Lafortune L; Kelly S; Hyde C; Brayne C
    J Alzheimers Dis; 2018; 64(4):1175-1194. PubMed ID: 30010119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Alzheimers Dis; 2016 Apr; 52(4):1385-401. PubMed ID: 27079727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spatio-temporal convolution for classification of alzheimer disease and mild cognitive impairment.
    Turhan G; Küçük H; Isik EO
    Comput Methods Programs Biomed; 2022 Jun; 221():106825. PubMed ID: 35636355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive Disintegration of Brain Networking from Normal Aging to Alzheimer Disease: Analysis of Independent Components of
    Pagani M; Giuliani A; Öberg J; De Carli F; Morbelli S; Girtler N; Arnaldi D; Accardo J; Bauckneht M; Bongioanni F; Chincarini A; Sambuceti G; Jonsson C; Nobili F
    J Nucl Med; 2017 Jul; 58(7):1132-1139. PubMed ID: 28280223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimodal Classification of Mild Cognitive Impairment Based on Partial Least Squares.
    Wang P; Chen K; Yao L; Hu B; Wu X; Zhang J; Ye Q; Guo X;
    J Alzheimers Dis; 2016 Aug; 54(1):359-71. PubMed ID: 27567818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiscale spatial gradient features for
    Pan X; Adel M; Fossati C; Gaidon T; Wojak J; Guedj E;
    Comput Methods Programs Biomed; 2019 Oct; 180():105027. PubMed ID: 31430595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Neurosci Methods; 2015 Dec; 256():168-83. PubMed ID: 26318777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-modal cross-attention network for Alzheimer's disease diagnosis with multi-modality data.
    Zhang J; He X; Liu Y; Cai Q; Chen H; Qing L
    Comput Biol Med; 2023 Aug; 162():107050. PubMed ID: 37269680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.